Cargando…
Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova
Introduction: In Italy, on December 2020, workers in the education sector were identified as a priority population to be vaccinated against COVID-19. The first authorised vaccines were the Pfizer-BioNTech mRNA (BNT162b2) and the Oxford-AstraZeneca adenovirus vectored (ChAdOx1 nCoV-19) vaccines. Aim:...
Autores principales: | Mason, Paola, Rizzuto, Rosario, Iannelli, Luca, Baccaglini, Flavio, Rizzolo, Valerio, Baraldo, Andrea, Melloni, Barbara, Maffione, Francesca, Pezzoli, Camilla, Chiozza, Maria Laura, Rupolo, Giampietro, Biasioli, Marco, Liviero, Filippo, Scapellato, Maria Luisa, Trevisan, Andrea, Merigliano, Stefano, Scuttari, Alberto, Moretto, Angelo, Scarpa, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221025/ https://www.ncbi.nlm.nih.gov/pubmed/37243055 http://dx.doi.org/10.3390/vaccines11050951 |
Ejemplares similares
-
The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave
por: Basso, Daniela, et al.
Publicado: (2022) -
Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers
por: Trevisan, Andrea, et al.
Publicado: (2021) -
Antinori INFN Padova
Publicado: (2016) -
Summary of the Padova workshop
por: Kifune, T
Publicado: (1995) -
Wolfgang Pauli in Padova
por: Unknown
Publicado: (1957)